Publications by authors named "Raymond Paranal"

Claim this Profile
U
Understanding familial risk of pancreatic ductal adenocarcinoma.
Raymond M Paranal, Laura D Wood, Alison P Klein, Nicholas J Roberts

Fam Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic loss of ATM is a late event in pancreatic tumorigenesis.
Raymond M Paranal, Zhengdong Jiang, Danielle Hutchings, Valentyna Kryklyva, Christian Gauthier

J Pathol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer.
Biagio Ricciuti, Jieun Son, Jeffrey J Okoro, Alessia Mira, Enrico Patrucco, Raymond Paranal

Clin Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance.
Hirokazu Kimura, Raymond M Paranal, Neha Nanda, Laura D Wood, James R Eshleman

Elife· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of -mutant lung cancer.
Pınar Özden Eser, Raymond M Paranal, Jieun Son, Elena Ivanova, Yanan Kuang

Sci Transl Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.
Chiara Ambrogio, Jens Köhler, Zhi-Wei Zhou, Haiyun Wang, Raymond Paranal

Cell· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C.
Mei Zeng, Jia Lu, Lianbo Li, Frederic Feru, Chunshan Quan, Raymond M Paranal

Cell Chem Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors.
Takayuki Kosaka, Junko Tanizaki, Raymond M Paranal, Hideki Endoh, Christine Lydon

Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivatives.
Samar Mowafy, A Galanis, Zainab M Doctor, Raymond M Paranal, Deena S Lasheen

Bioorg Med Chem· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis